mp:V3.0.0 testgegevens medicatiegegevensMGSMGO MVE addendum: verschil tussen versies
Naar navigatie springen
Naar zoeken springen
live 02-07-2024 |
k Tekst vervangen - "__NUMBEREDHEADINGS__" door "" |
||
| (5 tussenliggende versies door 4 gebruikers niet weergegeven) | |||
| Regel 1: | Regel 1: | ||
{{DISPLAYTITLE:Sturen medicatiegegevens MP9 3.0 - MVE: addendum inhoudelijke gegevens test}} | {{DISPLAYTITLE:Sturen medicatiegegevens MP9 3.0 - MVE: addendum inhoudelijke gegevens test}} | ||
| Regel 12: | Regel 12: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1|| || || MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | |1|| || || MBH_300_chronisch-tmgs|| MBH_300_chronisch_MVE-tmgs<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2|| || || MBH_300_toelichting<br/>MBH_300_aanvullendeinformatiewensen|| MBH_300_toelichting_MVE<br/>MBH_300_aanvullendeinformatiewensen_MVE | |2|| || || MBH_300_toelichting-tmgs<br/>MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_toelichting_MVE-tmgs<br/>MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7|| || || MBH_300_magistraalalleingredienten<br/>MBH_300_magistraalactieveingredient<br/>MBH_300_magistraal90miljoennr<br/>MBH_300_vrijetekstproduct|| MBH_300_magistraalalleingredienten_MVE<br/>MBH_300_magistraalactieveingredient_MVE<br/>MBH_300_magistraal90miljoennr_MVE<br/>MBH_300_vrijetekstproduct_MVE | |7|| || || MBH_300_magistraalalleingredienten-tmgs<br/>MBH_300_magistraalactieveingredient-tmgs<br/>MBH_300_magistraal90miljoennr-tmgs<br/>MBH_300_vrijetekstproduct-tmgs|| MBH_300_magistraalalleingredienten_MVE-tmgs<br/>MBH_300_magistraalactieveingredient_MVE-tmgs<br/>MBH_300_magistraal90miljoennr_MVE-tmgs<br/>MBH_300_vrijetekstproduct_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9|| || || | |9|| || || MBH_300_logistiekeverbruiksperiode_start_eind-tmgs<br/>MBH_300_distributievorm_GDS-tmgs<br/>MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs<br/>MBH_300_herhalingen-tmgs<br/>MBH_300_afleverlocatie-tmgs|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs<br/>MBH_300_distributievorm_GDS_MVE-tmgs<br/>MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs<br/>MBH_300_herhalingen_MVE1-tmgs<br/>MBH_300_herhalingen_MVE2-tmgs<br/>MBH_300_herhalingen_MVE3-tmgs<br/>MBH_300_afleverlocatie_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|10|| || || MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | |10|| || || MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGB- /> | <section end=overview-MGB- /> | ||
| Regel 29: | Regel 29: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.1|| || <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | |1.1|| || <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch-tmgs|| MBH_300_chronisch_MVE-tmgs<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|} | |} | ||
<section end=overview-MGB-1 /> | <section end=overview-MGB-1 /> | ||
| Regel 38: | Regel 38: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MVE | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting-tmgs|| MBH_300_toelichting_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_MVE | |2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGB-2 /> | <section end=overview-MGB-2 /> | ||
| Regel 49: | Regel 49: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MVE | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmgs|| MBH_300_magistraalalleingredienten_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MVE | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmgs|| MBH_300_magistraalactieveingredient_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_MVE | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmgs|| MBH_300_magistraal90miljoennr_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_MVE | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmgs|| MBH_300_vrijetekstproduct_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGB-7 /> | <section end=overview-MGB-7 /> | ||
| Regel 64: | Regel 64: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.1b|| || GDS|| MBH_300_distributievorm_GDS|| MBH_300_distributievorm_GDS_MVE | |9.1a|| || Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tmgs|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |||
|9.1b|| || GDS|| MBH_300_distributievorm_GDS-tmgs|| MBH_300_distributievorm_GDS_MVE-tmgs | |||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.1c|| || Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE | |9.1c|| || Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.2|| || Herhalende MVE onder een VV|| MBH_300_herhalingen|| MBH_300_herhalingen_MVE1<br/>MBH_300_herhalingen_MVE2<br/>MBH_300_herhalingen_MVE3 | |9.2|| || Herhalende MVE onder een VV|| MBH_300_herhalingen-tmgs|| MBH_300_herhalingen_MVE1-tmgs<br/>MBH_300_herhalingen_MVE2-tmgs<br/>MBH_300_herhalingen_MVE3-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie|| MBH_300_afleverlocatie_MVE | |9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie-tmgs|| MBH_300_afleverlocatie_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGB-9 /> | <section end=overview-MGB-9 /> | ||
| Regel 79: | Regel 81: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGB-10 /> | <section end=overview-MGB-10 /> | ||
| Regel 90: | Regel 92: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1|| || MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | |1|| || MBH_300_chronisch-tmgs|| MBH_300_chronisch_MVE-tmgs<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2|| || MBH_300_toelichting<br/>MBH_300_aanvullendeinformatiewensen|| MBH_300_toelichting_MVE<br/>MBH_300_aanvullendeinformatiewensen_MVE | |2|| || MBH_300_toelichting-tmgs<br/>MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_toelichting_MVE-tmgs<br/>MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7|| || MBH_300_magistraalalleingredienten<br/>MBH_300_magistraalactieveingredient<br/>MBH_300_magistraal90miljoennr<br/>MBH_300_vrijetekstproduct|| MBH_300_magistraalalleingredienten_MVE<br/>MBH_300_magistraalactieveingredient_MVE<br/>MBH_300_magistraal90miljoennr_MVE<br/>MBH_300_vrijetekstproduct_MVE | |7|| || MBH_300_magistraalalleingredienten-tmgs<br/>MBH_300_magistraalactieveingredient-tmgs<br/>MBH_300_magistraal90miljoennr-tmgs<br/>MBH_300_vrijetekstproduct-tmgs|| MBH_300_magistraalalleingredienten_MVE-tmgs<br/>MBH_300_magistraalactieveingredient_MVE-tmgs<br/>MBH_300_magistraal90miljoennr_MVE-tmgs<br/>MBH_300_vrijetekstproduct_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9|| || | |9|| || MBH_300_logistiekeverbruiksperiode_start_eind-tmgs<br/>MBH_300_distributievorm_GDS-tmgs<br/>MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs<br/>MBH_300_herhalingen-tmgs<br/>MBH_300_afleverlocatie-tmgs|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs<br/>MBH_300_distributievorm_GDS_MVE-tmgs<br/>MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs<br/>MBH_300_herhalingen_MVE1-tmgs<br/>MBH_300_herhalingen_MVE2-tmgs<br/>MBH_300_herhalingen_MVE3-tmgs<br/>MBH_300_afleverlocatie_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|10|| || MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | |10|| || MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGR- /> | <section end=overview-MGR- /> | ||
| Regel 107: | Regel 109: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|1.1|| <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | |1.1|| <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch-tmgs|| MBH_300_chronisch_MVE-tmgs<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|} | |} | ||
<section end=overview-MGR-1 /> | <section end=overview-MGR-1 /> | ||
| Regel 116: | Regel 118: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2.1|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MVE | |2.1|| Toelichting|| MBH_300_toelichting-tmgs|| MBH_300_toelichting_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|2.2|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_MVE | |2.2|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGR-2 /> | <section end=overview-MGR-2 /> | ||
| Regel 127: | Regel 129: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MVE | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmgs|| MBH_300_magistraalalleingredienten_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_MVE | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmgs|| MBH_300_magistraalactieveingredient_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_MVE | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmgs|| MBH_300_magistraal90miljoennr_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_MVE | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmgs|| MBH_300_vrijetekstproduct_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGR-7 /> | <section end=overview-MGR-7 /> | ||
| Regel 142: | Regel 144: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.1b|| GDS|| MBH_300_distributievorm_GDS|| MBH_300_distributievorm_GDS_MVE | |9.1a|| Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tmgs|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |||
|9.1b|| GDS|| MBH_300_distributievorm_GDS-tmgs|| MBH_300_distributievorm_GDS_MVE-tmgs | |||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.1c|| Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE | |9.1c|| Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.2|| Herhalende MVE onder een VV|| MBH_300_herhalingen|| MBH_300_herhalingen_MVE1<br/>MBH_300_herhalingen_MVE2<br/>MBH_300_herhalingen_MVE3 | |9.2|| Herhalende MVE onder een VV|| MBH_300_herhalingen-tmgs|| MBH_300_herhalingen_MVE1-tmgs<br/>MBH_300_herhalingen_MVE2-tmgs<br/>MBH_300_herhalingen_MVE3-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|9.3|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie|| MBH_300_afleverlocatie_MVE | |9.3|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie-tmgs|| MBH_300_afleverlocatie_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGR-9 /> | <section end=overview-MGR-9 /> | ||
| Regel 157: | Regel 161: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|} | |} | ||
<section end=overview-MGR-10 /> | <section end=overview-MGR-10 /> | ||
| Regel 195: | Regel 199: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /> | ||
==== Scenario 1 - MBH_300_chronisch==== | ==== Scenario 1 - MBH_300_chronisch-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 205: | Regel 209: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_chronisch_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |style="background-color: white;"|T - 30 dagen om 12:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 215: | Regel 219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 229: | Regel 233: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_chronisch_VV | |style="background-color: white;"|MBH_300_chronisch_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 243: | Regel 247: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 10 dagen om 12:35 uur | |style="background-color: white;"|T - 10 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 253: | Regel 257: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 267: | Regel 271: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA | |style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 281: | Regel 285: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset1-v30 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 1== | == TEST Medicatiegegevens MVE Scenarioset 1== | ||
| Regel 326: | Regel 333: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /> | ||
==== Scenario 1.1 - MBH_300_chronisch==== | ==== Scenario 1.1 - MBH_300_chronisch-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 336: | Regel 343: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_chronisch_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_chronisch_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |style="background-color: white;"|T - 30 dagen om 12:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 346: | Regel 353: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 360: | Regel 367: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_chronisch_VV | |style="background-color: white;"|MBH_300_chronisch_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 374: | Regel 381: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 10 dagen om 12:35 uur | |style="background-color: white;"|T - 10 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 384: | Regel 391: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 398: | Regel 405: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA | |style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 412: | Regel 419: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset1-v30-1-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 2== | == TEST Medicatiegegevens MVE Scenarioset 2== | ||
| Regel 457: | Regel 467: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /> | ||
==== Scenario 2.1 - MBH_300_toelichting==== | ==== Scenario 2.1 - MBH_300_toelichting-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 467: | Regel 477: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_toelichting_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 21 dagen om 09:02 uur | |style="background-color: white;"|T - 21 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 477: | Regel 487: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 494: | Regel 504: | ||
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_toelichting_VV | |style="background-color: white;"|MBH_300_toelichting_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 508: | Regel 518: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset2-v30-2-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 2== | == TEST Medicatiegegevens MVE Scenarioset 2== | ||
| Regel 553: | Regel 566: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /> | ||
==== Scenario 2 - MBH_300_toelichting==== | ==== Scenario 2 - MBH_300_toelichting-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 563: | Regel 576: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_toelichting_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 21 dagen om 09:02 uur | |style="background-color: white;"|T - 21 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 573: | Regel 586: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 590: | Regel 603: | ||
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_toelichting_VV | |style="background-color: white;"|MBH_300_toelichting_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Scenario 2 - MBH_300_aanvullendeinformatiewensen==== | ==== Scenario 2 - MBH_300_aanvullendeinformatiewensen-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 606: | Regel 619: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 5 dagen om 09:06 uur | |style="background-color: white;"|T - 5 dagen om 09:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 616: | Regel 629: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 628: | Regel 641: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|FENETICILLINE 500MG | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingAanvullendeInformatie | ||
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 647: | Regel 660: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset2-v30 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 2== | == TEST Medicatiegegevens MVE Scenarioset 2== | ||
| Regel 692: | Regel 708: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /> | ||
==== Scenario 2.2 - MBH_300_aanvullendeinformatiewensen==== | ==== Scenario 2.2 - MBH_300_aanvullendeinformatiewensen-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 702: | Regel 718: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 5 dagen om 09:06 uur | |style="background-color: white;"|T - 5 dagen om 09:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 712: | Regel 728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|40 stuks | |style="background-color: white;"|40 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 724: | Regel 740: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|FENETICILLINE 500MG | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingAanvullendeInformatie | ||
|style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 743: | Regel 759: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /><section end=mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /><section end=mg-mp-smg-tst-MVE-Scenarioset2-v30-2-2 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 788: | Regel 807: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /> | ||
==== Scenario 7.1 - MBH_300_magistraalalleingredienten==== | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 798: | Regel 817: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 808: | Regel 827: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|50 ml | |style="background-color: white;"|50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 827: | Regel 846: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 837: | Regel 856: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 843: | Regel 862: | ||
|style="background-color: white;"|90 gram per 100 gram | |style="background-color: white;"|90 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten_VV | |style="background-color: white;"|MBH_300_magistraalalleingredienten_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 857: | Regel 876: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 902: | Regel 924: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /> | ||
==== Scenario 7.2 - MBH_300_magistraalactieveingredient==== | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 912: | Regel 934: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 922: | Regel 944: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|75 gram | |style="background-color: white;"|75 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 941: | Regel 963: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 947: | Regel 969: | ||
|style="background-color: white;"|80 gram per 100 gram | |style="background-color: white;"|80 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient_VV | |style="background-color: white;"|MBH_300_magistraalactieveingredient_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 961: | Regel 983: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-2 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.006: | Regel 1.031: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /> | ||
==== Scenario 7.3 - MBH_300_magistraal90miljoennr==== | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.016: | Regel 1.041: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:08 uur | |style="background-color: white;"|T om 13:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.026: | Regel 1.051: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductCode | ||
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.048: | Regel 1.073: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.054: | Regel 1.079: | ||
|style="background-color: white;"|10 gram per 100 gram | |style="background-color: white;"|10 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr_VV | |style="background-color: white;"|MBH_300_magistraal90miljoennr_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.068: | Regel 1.093: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-3 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.113: | Regel 1.141: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /> | ||
==== Scenario 7.4 - MBH_300_vrijetekstproduct==== | ==== Scenario 7.4 - MBH_300_vrijetekstproduct-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.123: | Regel 1.151: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_vrijetekstproduct_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 1 dag om 15:50 uur | |style="background-color: white;"|T - 1 dag om 15:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.133: | Regel 1.161: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|4 stuks | |style="background-color: white;"|4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - | |colspan="4"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ProductNaam | ||
|style="background-color: white;"|Jemperli 500 mg/ 10 mL | |style="background-color: white;"|Jemperli 500 mg/ 10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.148: | Regel 1.176: | ||
|style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct_VV | |style="background-color: white;"|MBH_300_vrijetekstproduct_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.162: | Regel 1.190: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /><section end=mg-mp-smg-tst-MVE-Scenarioset7-v30-7-4 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.207: | Regel 1.238: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /> | ||
==== Scenario 7 - MBH_300_magistraalalleingredienten==== | ==== Scenario 7 - MBH_300_magistraalalleingredienten-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.217: | Regel 1.248: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.227: | Regel 1.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|50 ml | |style="background-color: white;"|50 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.246: | Regel 1.277: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.256: | Regel 1.287: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.262: | Regel 1.293: | ||
|style="background-color: white;"|90 gram per 100 gram | |style="background-color: white;"|90 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten_VV | |style="background-color: white;"|MBH_300_magistraalalleingredienten_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Scenario 7 - MBH_300_magistraalactieveingredient==== | ==== Scenario 7 - MBH_300_magistraalactieveingredient-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.278: | Regel 1.309: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.288: | Regel 1.319: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|75 gram | |style="background-color: white;"|75 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.307: | Regel 1.338: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.313: | Regel 1.344: | ||
|style="background-color: white;"|80 gram per 100 gram | |style="background-color: white;"|80 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient_VV | |style="background-color: white;"|MBH_300_magistraalactieveingredient_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Scenario 7 - MBH_300_magistraal90miljoennr==== | ==== Scenario 7 - MBH_300_magistraal90miljoennr-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.329: | Regel 1.360: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 13:08 uur | |style="background-color: white;"|T om 13:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.339: | Regel 1.370: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Geneesmiddel - | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductCode | ||
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|ProductNaam | ||
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.361: | Regel 1.392: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|IngredientCode | ||
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.367: | Regel 1.398: | ||
|style="background-color: white;"|10 gram per 100 gram | |style="background-color: white;"|10 gram per 100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr_VV | |style="background-color: white;"|MBH_300_magistraal90miljoennr_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Scenario 7 - MBH_300_vrijetekstproduct==== | ==== Scenario 7 - MBH_300_vrijetekstproduct-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.383: | Regel 1.414: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_vrijetekstproduct_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T - 1 dag om 15:50 uur | |style="background-color: white;"|T - 1 dag om 15:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.393: | Regel 1.424: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|4 stuks | |style="background-color: white;"|4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - | |colspan="4"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ProductNaam | ||
|style="background-color: white;"|Jemperli 500 mg/ 10 mL | |style="background-color: white;"|Jemperli 500 mg/ 10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.408: | Regel 1.439: | ||
|style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct_VV | |style="background-color: white;"|MBH_300_vrijetekstproduct_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.422: | Regel 1.453: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset7-v30 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
<section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | <section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /><section begin=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.466: | Regel 1.500: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /> | ||
==== Scenario 9. | ==== Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.477: | Regel 1.511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T | |style="background-color: white;"|T om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.487: | Regel 1.521: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|100 stuks | |style="background-color: white;"|100 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Verbruiksduur | |||
|style="background-color: white;"|100 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.518: | Regel 1.552: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /><section end=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1a /> | |||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
<section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | <section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /><section begin=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.562: | Regel 1.599: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /> | ||
==== Scenario 9. | ==== Scenario 9.1b - MBH_300_distributievorm_GDS-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.573: | Regel 1.610: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_distributievorm_GDS_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 12: | |style="background-color: white;"|T - 9 dagen om 12:01 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.583: | Regel 1.620: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|14 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verbruiksduur | |colspan="3"|Verbruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Distributievorm | |||
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_distributievorm_GDS_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_distributievorm_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.614: | Regel 1.654: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /><section end=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1b /> | |||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
<section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | <section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /><section begin=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.658: | Regel 1.701: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /> | ||
==== Scenario 9. | ==== Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.669: | Regel 1.712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T | |style="background-color: white;"|T om 12:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.679: | Regel 1.722: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|50 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Verbruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"| | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Adresgegevens | ||
|style="background-color: white;"| | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /><section end=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-1c /> | |||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | |||
<section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /><section begin=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /> | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan=" | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="6"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Initialen | ||
|style="background-color: white;"| | |style="background-color: white;"|M. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Naamgebruik | ||
|style="background-color: white;"| | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"| | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Nederveen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="4"|Identificatienummer | ||
|style="background-color: white;"|999900833 [BSN] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geboortedatum | |||
|style="background-color: white;"|28 okt 1985 | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslacht | |||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /> | |||
==== Scenario 9.2 - MBH_300_herhalingen-tmgs==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE1-tmgs | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_herhalingen_MVE1-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T - 50 dagen om 12:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.769: | Regel 1.835: | ||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_herhalingen_VV | |style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE2-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_herhalingen_MVE2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"| | |style="background-color: white;"|T - 20 dagen om 10:24:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Verstrekker | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"| | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"| | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE3-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.838: | Regel 1.887: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen_MVE3-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om | |style="background-color: white;"|T + 10 dagen om 09:46:48 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.851: | Regel 1.897: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.882: | Regel 1.925: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9- | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /><section end=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-2 /> | |||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
<section begin= | <section begin=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /><section begin=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.926: | Regel 1.972: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient- | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /> | ||
==== Scenario 9 - MBH_300_afleverlocatie==== | ==== Scenario 9.3 - MBH_300_afleverlocatie-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_afleverlocatie_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.937: | Regel 1.983: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_afleverlocatie_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_afleverlocatie_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 12:07 uur | |style="background-color: white;"|T om 12:07 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|AanschrijfDatum | ||
|style="background-color: white;"|T om 11:07 uur | |style="background-color: white;"|T om 11:07 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.950: | Regel 1.996: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.967: | Regel 2.013: | ||
|style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_afleverlocatie_VV | |style="background-color: white;"|MBH_300_afleverlocatie_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_afleverlocatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_afleverlocatie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|Adresgegevens | ||
|style="background-color: white;"| | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /><section end=mg-mp-smg-tst-MVE-Scenarioset9-v30-9-3 /> | |||
== TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | |||
<section begin=mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /><section begin=patient-mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /> | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="4" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="5"|Naamgegevens | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Initialen | ||
|style="background-color: white;"| | |style="background-color: white;"|M. | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Naamgebruik | |||
|style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Geslachtsnaam | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="2"|Achternaam | ||
|style="background-color: white;"| | |style="background-color: white;"|XXX_Nederveen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Identificatienummer | ||
|style="background-color: white;"| | |style="background-color: white;"|999900833 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geboortedatum | ||
|style="background-color: white;"| | |style="background-color: white;"|28 okt 1985 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan=" | |colspan="4"|Geslacht | ||
|style="background-color: white;"| | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|} | |}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /> | ||
==== Scenario 9 - | ==== Scenario 9 - MBH_300_logistiekeverbruiksperiode_start_eind-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.026: | Regel 2.085: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 12: | |style="background-color: white;"|T om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.036: | Regel 2.095: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|100 stuks | |style="background-color: white;"|100 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Verbruiksduur | |colspan="3"|Verbruiksduur | ||
|style="background-color: white;"| | |style="background-color: white;"|100 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
==== Scenario 9 - MBH_300_distributievorm_GDS-tmgs==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmgs | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_distributievorm_GDS_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T - 9 dagen om 12:01 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|14 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Verbruiksduur | |||
|style="background-color: white;"|14 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Distributievorm | |||
|style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|RelatieVerstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_distributievorm_GDS_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_distributievorm_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
==== Scenario 9 - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T om 12:02 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|50 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Verbruiksduur | |||
|style="background-color: white;"|50 dagen | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|RelatieVerstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
==== Scenario 9 - MBH_300_herhalingen-tmgs==== | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE1-tmgs | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_herhalingen_MVE1-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T - 50 dagen om 12:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|30 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|RelatieVerstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MBH identificatie | |||
|style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
|} | |||
{| class="wikitable" width="85%" | |||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE2-tmgs | |||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |||
|colspan="3" width="25%"| Gegevenselement | |||
|| Waarde | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Identificatie | |||
|style="background-color: white;"|MBH_300_herhalingen_MVE2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T - 20 dagen om 10:24:05 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="4"|Verstrekker | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|rowspan="2"| | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Zorgaanbieder | |||
|style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|VerstrekteHoeveelheid | |||
|style="background-color: white;"|30 stuks | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - primaire code | |||
|style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|Geneesmiddel - generiekere code | |||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|RelatieVerstrekkingsverzoek | |||
|style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE3-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.069: | Regel 2.293: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_herhalingen_MVE3-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T | |style="background-color: white;"|T + 10 dagen om 09:46:48 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.079: | Regel 2.303: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.093: | Regel 2.317: | ||
|style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_herhalingen_VV | |style="background-color: white;"|MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_herhalingen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Scenario 9 - MBH_300_afleverlocatie-tmgs==== | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.107: | Regel 2.333: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_afleverlocatie_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="3"|MedicatieverstrekkingsDatumTijd | |||
|style="background-color: white;"|T om 12:07 uur | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|AanschrijfDatum | ||
|style="background-color: white;"|T | |style="background-color: white;"|T om 11:07 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.117: | Regel 2.346: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"| | |style="background-color: white;"|MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"| | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|Afleverlocatie | ||
|style="background-color: white;"| | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_afleverlocatie_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"| | |style="background-color: white;"|MBH_300_afleverlocatie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.183: | Regel 2.377: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset9-v30 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 10 (ZI)== | == TEST Medicatiegegevens MVE Scenarioset 10 (ZI)== | ||
| Regel 2.228: | Regel 2.425: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /> | |}<section end=patient-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /> | ||
==== Scenario 10.1 - MBH_300_ZINRvoorschrijven==== | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.238: | Regel 2.435: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 14:05 uur | |style="background-color: white;"|T om 14:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.248: | Regel 2.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|150 stuks | |style="background-color: white;"|150 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|INDAPAMIDE | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|INDAPAMIDE | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 2.265: | Regel 2.462: | ||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.279: | Regel 2.476: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /> | |}<section end=mbhs-mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /><section end=mg-mp-smg-tst-MVE-Scenarioset10-v30-10-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 10 (ZI)== | == TEST Medicatiegegevens MVE Scenarioset 10 (ZI)== | ||
| Regel 2.324: | Regel 2.524: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /><section begin=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /> | ||
==== Scenario 10 - MBH_300_ZINRvoorschrijven==== | ==== Scenario 10 - MBH_300_ZINRvoorschrijven-tmgs==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmgs | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.334: | Regel 2.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
|style="background-color: white;"|T om 14:05 uur | |style="background-color: white;"|T om 14:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.344: | Regel 2.544: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
|style="background-color: white;"|Zie [[# | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|VerstrekteHoeveelheid | ||
|style="background-color: white;"|150 stuks | |style="background-color: white;"|150 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
|style="background-color: white;"|INDAPAMIDE | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|INDAPAMIDE | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 2.361: | Regel 2.561: | ||
|style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"| | |colspan="3"|RelatieVerstrekkingsverzoek | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.375: | Regel 2.575: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|<span id=" | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan=" | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"| | |colspan="2"|OrganisatieNaam | ||
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |||
|colspan="2"|Adresgegevens | |||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
|}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /><section end=mgsets-mp-smg-tst-MVE-Scenarioset10-v30 /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] | ||
Huidige versie van 22 okt 2026 18:11
1 Addenda voor inhoudelijke gegevens[bewerken]
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem[bewerken]
1.1.1 Scenarioset[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 1 | MBH_300_chronisch-tmgs | MBH_300_chronisch_MVE-tmgs MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | ||
| 2 | MBH_300_toelichting-tmgs MBH_300_aanvullendeinformatiewensen-tmgs |
MBH_300_toelichting_MVE-tmgs MBH_300_aanvullendeinformatiewensen_MVE-tmgs | ||
| 7 | MBH_300_magistraalalleingredienten-tmgs MBH_300_magistraalactieveingredient-tmgs MBH_300_magistraal90miljoennr-tmgs MBH_300_vrijetekstproduct-tmgs |
MBH_300_magistraalalleingredienten_MVE-tmgs MBH_300_magistraalactieveingredient_MVE-tmgs MBH_300_magistraal90miljoennr_MVE-tmgs MBH_300_vrijetekstproduct_MVE-tmgs | ||
| 9 | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs MBH_300_distributievorm_GDS-tmgs MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs MBH_300_herhalingen-tmgs MBH_300_afleverlocatie-tmgs |
MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs MBH_300_distributievorm_GDS_MVE-tmgs MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs MBH_300_herhalingen_MVE1-tmgs MBH_300_herhalingen_MVE2-tmgs MBH_300_herhalingen_MVE3-tmgs MBH_300_afleverlocatie_MVE-tmgs | ||
| 10 | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_MVE-tmgs |
1.1.2 Scenarioset 1[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 1.1 | Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie) |
MBH_300_chronisch-tmgs | MBH_300_chronisch_MVE-tmgs MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs |
1.1.3 Scenarioset 2[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 2.1 | Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden | Toelichting | MBH_300_toelichting-tmgs | MBH_300_toelichting_MVE-tmgs |
| 2.2 | Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmgs | MBH_300_aanvullendeinformatiewensen_MVE-tmgs |
1.1.4 Scenarioset 7[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmgs | MBH_300_magistraalalleingredienten_MVE-tmgs |
| 7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmgs | MBH_300_magistraalactieveingredient_MVE-tmgs |
| 7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmgs | MBH_300_magistraal90miljoennr_MVE-tmgs |
| 7.4 | Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt | Vrije tekst product | MBH_300_vrijetekstproduct-tmgs | MBH_300_vrijetekstproduct_MVE-tmgs |
1.1.5 Scenarioset 9[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 9.1a | Logistieke verbruiksperiode | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | |
| 9.1b | GDS | MBH_300_distributievorm_GDS-tmgs | MBH_300_distributievorm_GDS_MVE-tmgs | |
| 9.1c | Verbruiksduur | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | |
| 9.2 | Herhalende MVE onder een VV | MBH_300_herhalingen-tmgs | MBH_300_herhalingen_MVE1-tmgs MBH_300_herhalingen_MVE2-tmgs MBH_300_herhalingen_MVE3-tmgs | |
| 9.3 | Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden | Afleverlocatie en aanschrijfdatum | MBH_300_afleverlocatie-tmgs | MBH_300_afleverlocatie_MVE-tmgs |
1.1.6 Scenarioset 10[bewerken]
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_MVE-tmgs |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem[bewerken]
1.2.1 Scenarioset[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 1 | MBH_300_chronisch-tmgs | MBH_300_chronisch_MVE-tmgs MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | |
| 2 | MBH_300_toelichting-tmgs MBH_300_aanvullendeinformatiewensen-tmgs |
MBH_300_toelichting_MVE-tmgs MBH_300_aanvullendeinformatiewensen_MVE-tmgs | |
| 7 | MBH_300_magistraalalleingredienten-tmgs MBH_300_magistraalactieveingredient-tmgs MBH_300_magistraal90miljoennr-tmgs MBH_300_vrijetekstproduct-tmgs |
MBH_300_magistraalalleingredienten_MVE-tmgs MBH_300_magistraalactieveingredient_MVE-tmgs MBH_300_magistraal90miljoennr_MVE-tmgs MBH_300_vrijetekstproduct_MVE-tmgs | |
| 9 | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs MBH_300_distributievorm_GDS-tmgs MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs MBH_300_herhalingen-tmgs MBH_300_afleverlocatie-tmgs |
MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs MBH_300_distributievorm_GDS_MVE-tmgs MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs MBH_300_herhalingen_MVE1-tmgs MBH_300_herhalingen_MVE2-tmgs MBH_300_herhalingen_MVE3-tmgs MBH_300_afleverlocatie_MVE-tmgs | |
| 10 | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_MVE-tmgs |
1.2.2 Scenarioset 1[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 1.1 | Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie) |
MBH_300_chronisch-tmgs | MBH_300_chronisch_MVE-tmgs MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs |
1.2.3 Scenarioset 2[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 2.1 | Toelichting | MBH_300_toelichting-tmgs | MBH_300_toelichting_MVE-tmgs |
| 2.2 | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmgs | MBH_300_aanvullendeinformatiewensen_MVE-tmgs |
1.2.4 Scenarioset 7[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 7.1 | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmgs | MBH_300_magistraalalleingredienten_MVE-tmgs |
| 7.2 | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmgs | MBH_300_magistraalactieveingredient_MVE-tmgs |
| 7.3 | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmgs | MBH_300_magistraal90miljoennr_MVE-tmgs |
| 7.4 | Vrije tekst product | MBH_300_vrijetekstproduct-tmgs | MBH_300_vrijetekstproduct_MVE-tmgs |
1.2.5 Scenarioset 9[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 9.1a | Logistieke verbruiksperiode | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs |
| 9.1b | GDS | MBH_300_distributievorm_GDS-tmgs | MBH_300_distributievorm_GDS_MVE-tmgs |
| 9.1c | Verbruiksduur | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs |
| 9.2 | Herhalende MVE onder een VV | MBH_300_herhalingen-tmgs | MBH_300_herhalingen_MVE1-tmgs MBH_300_herhalingen_MVE2-tmgs MBH_300_herhalingen_MVE3-tmgs |
| 9.3 | Afleverlocatie en aanschrijfdatum | MBH_300_afleverlocatie-tmgs | MBH_300_afleverlocatie_MVE-tmgs |
1.2.6 Scenarioset 10[bewerken]
| Scenario | Beschrijving | MBH id | MVE id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_MVE-tmgs |
1.3 TEST Medicatiegegevens MVE Scenarioset 1[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Scenario 1 - MBH_300_chronisch-tmgs[bewerken]
| Medicatieverstrekking MBH_300_chronisch_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 30 dagen om 12:32 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 12:35 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV_extraVVbestaandeMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.4 TEST Medicatiegegevens MVE Scenarioset 1[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Scenario 1.1 - MBH_300_chronisch-tmgs[bewerken]
| Medicatieverstrekking MBH_300_chronisch_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 30 dagen om 12:32 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 12:35 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV_extraVVbestaandeMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.4.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.5 TEST Medicatiegegevens MVE Scenarioset 2[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Scenario 2.1 - MBH_300_toelichting-tmgs[bewerken]
| Medicatieverstrekking MBH_300_toelichting_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 21 dagen om 09:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
| RelatieVerstrekkingsverzoek | MBH_300_toelichting_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.5.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.6 TEST Medicatiegegevens MVE Scenarioset 2[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Scenario 2 - MBH_300_toelichting-tmgs[bewerken]
| Medicatieverstrekking MBH_300_toelichting_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 21 dagen om 09:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
| RelatieVerstrekkingsverzoek | MBH_300_toelichting_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.2 Scenario 2 - MBH_300_aanvullendeinformatiewensen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:06 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 40 stuks | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| MedicatieverstrekkingAanvullendeInformatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
| RelatieVerstrekkingsverzoek | MBH_300_aanvullendeinformatiewensen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.3 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.7 TEST Medicatiegegevens MVE Scenarioset 2[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Scenario 2.2 - MBH_300_aanvullendeinformatiewensen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:06 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 40 stuks | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| MedicatieverstrekkingAanvullendeInformatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
| RelatieVerstrekkingsverzoek | MBH_300_aanvullendeinformatiewensen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.8 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Scenario 7.1 - MBH_300_magistraalalleingredienten-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 50 ml | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalalleingredienten_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.8.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.9 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Scenario 7.2 - MBH_300_magistraalactieveingredient-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:05 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 75 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalactieveingredient_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.9.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.10 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Scenario 7.3 - MBH_300_magistraal90miljoennr-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:08 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 100 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraal90miljoennr_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.10.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.11 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Scenario 7.4 - MBH_300_vrijetekstproduct-tmgs[bewerken]
| Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 1 dag om 15:50 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 4 stuks | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| RelatieVerstrekkingsverzoek | MBH_300_vrijetekstproduct_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.12 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Scenario 7 - MBH_300_magistraalalleingredienten-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 50 ml | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalalleingredienten_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.12.2 Scenario 7 - MBH_300_magistraalactieveingredient-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:05 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 75 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalactieveingredient_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.12.3 Scenario 7 - MBH_300_magistraal90miljoennr-tmgs[bewerken]
| Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:08 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 100 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraal90miljoennr_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.12.4 Scenario 7 - MBH_300_vrijetekstproduct-tmgs[bewerken]
| Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 1 dag om 15:50 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 4 stuks | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| RelatieVerstrekkingsverzoek | MBH_300_vrijetekstproduct_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.12.5 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.13 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tmgs[bewerken]
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 100 stuks | ||
| Verbruiksduur | 100 dagen | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.13.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.14 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Scenario 9.1b - MBH_300_distributievorm_GDS-tmgs[bewerken]
| Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_distributievorm_GDS_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 9 dagen om 12:01 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 14 stuks | ||
| Verbruiksduur | 14 dagen | ||
| Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| RelatieVerstrekkingsverzoek | MBH_300_distributievorm_GDS_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_distributievorm_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.14.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.15 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 50 stuks | ||
| Verbruiksduur | 50 dagen | ||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.15.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.16 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.16.1 Scenario 9.2 - MBH_300_herhalingen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_herhalingen_MVE1-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE1-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 12:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE2-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 10:24:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE3-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE3-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T + 10 dagen om 09:46:48 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.16.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.17 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.17.1 Scenario 9.3 - MBH_300_afleverlocatie-tmgs[bewerken]
| Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afleverlocatie_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:07 uur | ||
| AanschrijfDatum | T om 11:07 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | ||
| RelatieVerstrekkingsverzoek | MBH_300_afleverlocatie_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_afleverlocatie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.17.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.18 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Nederveen | |||
| Identificatienummer | 999900833 [BSN] | |||
| Geboortedatum | 28 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.18.1 Scenario 9 - MBH_300_logistiekeverbruiksperiode_start_eind-tmgs[bewerken]
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 100 stuks | ||
| Verbruiksduur | 100 dagen | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.2 Scenario 9 - MBH_300_distributievorm_GDS-tmgs[bewerken]
| Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_distributievorm_GDS_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 9 dagen om 12:01 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 14 stuks | ||
| Verbruiksduur | 14 dagen | ||
| Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| RelatieVerstrekkingsverzoek | MBH_300_distributievorm_GDS_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_distributievorm_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.3 Scenario 9 - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 50 stuks | ||
| Verbruiksduur | 50 dagen | ||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.4 Scenario 9 - MBH_300_herhalingen-tmgs[bewerken]
| Medicatieverstrekking MBH_300_herhalingen_MVE1-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE1-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 12:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE2-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 10:24:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE3-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE3-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T + 10 dagen om 09:46:48 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.5 Scenario 9 - MBH_300_afleverlocatie-tmgs[bewerken]
| Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afleverlocatie_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:07 uur | ||
| AanschrijfDatum | T om 11:07 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | ||
| RelatieVerstrekkingsverzoek | MBH_300_afleverlocatie_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_afleverlocatie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.6 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.19 TEST Medicatiegegevens MVE Scenarioset 10 (ZI)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.19.1 Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmgs[bewerken]
| Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 14:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 150 stuks | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_ZINRvoorschrijven_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.19.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.20 TEST Medicatiegegevens MVE Scenarioset 10 (ZI)[bewerken]
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.20.1 Scenario 10 - MBH_300_ZINRvoorschrijven-tmgs[bewerken]
| Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_MVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 14:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 150 stuks | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_ZINRvoorschrijven_VV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.20.2 Bouwstenen[bewerken]
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||